Anavex Life Sciences
AVXL
#7368
Rank
NZ$0.71 B
Marketcap
NZ$7.75
Share price
-3.40%
Change (1 day)
-50.92%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.93

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.92. a decrease over its 2024 EPS that were of NZ-$0.89.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.923.85%
2024NZ-$0.89-13.33%
2023NZ-$1.02-3.23%
2022NZ-$1.0614.81%
2021NZ-$0.9220%
2020NZ-$0.77-16.67%
2019NZ-$0.9238.46%
2018NZ-$0.6618.18%
2017NZ-$0.56-21.43%
2016NZ-$0.72-35.38%
2015NZ-$1.11-36.27%
2014NZ-$1.74112.5%
2013NZ-$0.82-58.62%
2012NZ-$1.98-0%
2011NZ-$1.98-29.27%
2010NZ-$2.7951.85%
2009NZ-$1.84-0%
2008NZ-$1.84237.5%
2007NZ-$0.55
2006N/A-100%
2005NZ-$0.06816499.97%
2004NZ-$0.01136

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$4.07-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.70-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$50.95 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08519-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA